Immunohistochemical Analysis for p53 and TGF-beta Expression Pattern in Ovarian Epithelial Tumors.
- Author:
Jin Wan PARK
1
;
Moon Hee YOUN
;
Na Hye MYONG
Author Information
1. Department of Obstetrics and Gynecology, College of Medicine, Dan-Kook University, Cheonan, Korea.
- Publication Type:Original Article
- Keywords:
p53;
TGF-beta;
Immnunohistochemistry;
Ovarian epithelial tumors
- MeSH:
Epithelial Cells;
Hand;
Prevalence;
Transforming Growth Factor beta*
- From:Korean Journal of Obstetrics and Gynecology
2004;47(3):445-450
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To verify the pattern of p53 and TGF-beta protein expression in benign and malignant epithelial ovarian tumors. METHODS: An immunohistochemical technique was applied to formalin-fixed paraffin-embedded samples of 22 benign and 9 malignant epithelial ovarian tumors using p53 monoclonal antibody and TGF-beta polyclonal antibody. Expressions of p53 and TGF-beta protein in two histological types were compared, and correlated with clinico-pathologic findings of the respective cases. RESULTS: p53 immunoreactivity of high or intermediate degree was detected in 2 out of 22 benign (9%) and 5 out of 9 malignant (55%) cases. On the other hand, intermediate to high TGF-beta expression was found in 17 out of 22 benign (77%), and 3 out of 9 malignant (33%) cases. The prevalence differences of p53 and TGF-beta expression between benign and malignant groups were statistically significant (p<0.05). In addition, the prevalence of immunoreactivities of p53 and TGF-beta in malignant tumor didn't show any association with age, tumor size, histologic types and stage. CONCLUSION: Our results suggest that p53 expression and loss of TGF-beta expression may play an important role in the malignant transformation of ovarian epithelial cells. However further studies seem to be necessary to know the exact relationship between their roles.
